September 16, 2015 at 4:49 pm
This article in today’s Daily Mail UK describes the dangers of psychiatric drugs. There are over 80 million prescriptions for psychiatric drugs written a year in UK alone, making these drugs the third leading cause of death after heart disease and cancer.
Wendy Dolin (Founder) and Kim Witczak (Advisor) have been invited to share their personal family experience with anti-depressants at a conference this week in Copenhagen organized by author of this article, Dr. Peter Gotzsche of the Cochrane Collaboration. Dr. Gotzsche just wrote a new book titled, “Deadly Psychiatry And Organised Denial” and is featured in this article.
**MISSD is not anti-drug, but this article does discuss the dangers of medication-induced suicide.
http://www.dailymail.co.uk/health/article-3234334/Prescription-pills-Britain-s-biggest-killer-effects-drugs-taken-insomnia-anxiety-kill-thousands-doctors-hand-like-Smarties.html
July 27, 2015 at 11:59 pm
The mission of MISSD is to raise awareness about medication-induced suicides and akathisia. Departing slightly, but in conjunction with drug induced reactions, I want to share a personal story regarding my 94 1/2-year-old mother. My mother, who has age-related dementia, was prescribed Ritalin to help increase her appetite. Six days after starting Ritalin she had a complete break from reality-she experienced auditory and visual hallucinations, and a sensation of bugs crawling on her arms. She experienced many symptoms of akathisia, including aggressiveness, restlessness, agitation, insomnia, irritability and hostility. Once physical issues were ruled out, she was sent to a geriatric psychiatric ward for detox. Gratefully, after two weeks and a readjustment of meds, I am happy to report that she is back to her usual self. This experience broadened my perspective that we have to be aware of these reactions in all age groups and be vigilant when anyone stops or starts a new medication.
~Wendy Dolin
Founder of MISSD
April 14, 2015 at 3:50 pm
January 6, 2015 at 5:06 pm
Wendy Dolin, (founder) was asked to participate in the June 2014 National Center For Health Research Conference in Washington, DC. The objective for this workshop (which was led by 10 patient and consumer advocates) is to learn about the scientific evidence perspectives that the FDA then considers when making decisions to approve or recall a medical product. Wendy Dolin was one of the participants on this panel.
Below are some excerpts from an article summarizing the conference, with MISSD founder Wendy Dolin featured in one of the photos:
Page 1 (PDF)
Page 2 (PDF)
Page 3 (PDF)
November 29, 2014 at 7:57 pm
October 22, 2014 at 9:35 pm
Pfizer has recently presented Chantix to the FDA in efforts to remove the black box warning (although side effects of this drug are very serious and have lead to suicidal behavior). Chantix did NOT lose the black box warning, but here is a powerful video discussing some of the side effects of this drug.
September 29, 2014 at 4:13 pm
Small study investigates how brain cells react differently to SSRI’s.
“Experts said the hope is to eventually be able to predict which people with depression are likely to benefit from a drug — and which people would fare better with a different option.”
-Norton, A.; HealthDay News 9/18/2014
View the full article here.